Tissue concentrations of tissue polypeptide antigen (TPA) and prostatic specific antigen (PSA) in 42 patients with prostatic carcinoma

Prostate

Volumn 45, Issue 4, 2000, Pages 299-303

  Grande, Mirtha ^a   Carlstrm, Kjell ^a   Rozell, Barbro Lundh ^a   Eneroth, Peter ^a   Stege, Reinhard ^a   Pousette, Ke ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biopsy; Prognosis; Prostate; Prostate cancer; PSA; TPA

Indexed keywords

BIOCHEMICAL MARKER; CYTOKERATIN 18; CYTOKERATIN 19; PROSTATE SPECIFIC ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; ASPIRATION BIOPSY; CANCER PATIENT; CANCER SCREENING; CANCER SURVIVAL; DRUG TISSUE LEVEL; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CARCINOMA; TRANSCRIPTION REGULATION;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; TISSUE POLYPEPTIDE ANTIGEN;

EID: 0033668934     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20001201)45:4<299::AID-PROS3>3.0.CO;2-I     Document Type: Article

References (23)

1. PAP and PSA in prostatic carcinoma cell lines and aspiration biopsies: Relation to hormone sensitivity and to cytological grading
2. Deoxyribonucleic acid ploidy and the direct assay of prostatic acid phosphatase and prostate specific antigen in fine needle aspiration biopsies as diagnostic methods in prostatic carcinoma
3. Prognostic significance of tissue PSA in hormonally treated prostate carcinomas
4. On the nature and clinical use of tissue polypeptide antigen (TPA)
5. On the nature of serological tissue polypeptide antigen (TPA); monoclonal keratin 8, 18, 19 antibodies react differently with TPA prepared from human cultured carcinoma cells and TPA in human serum
6. Tissue polypeptide specific antigen (TPS) and objective response to treatment in solid tumors
7. Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen
8. TPS in breast cancer - A comparative study with carcinoembryonic antigen and CA 15-3
9. Tps - A cytokeratin marker for therapy control in breast cancer
10. Value of tissue polypeptide antigen (TPA/TPS) in urological tumors
11. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer
12. TPS in prostate cancer
13. Measurements of tissue polypeptide-specific antigen and prostate-specific antigen in prostate cancer patients under intermittent androgen suppression therapy
14. Tissue polypeptide-specific antigen (TPS) immunoassay in the diagnosis and clinical staging of prostatic carcinoma. Comparison with prostate-specific antigen (PSA)
15. Measurements of free and total PSA, tissue polypeptide-specific antigen (TPS), and CYFRA 21-1 in prostate cancer patients under intermittent androgen suppression therapy
16. Treatment of prostate cancer with gonadotropin-releasing hormone agonists
17. Possible bone-preserving capacity of high-dose intramuscular depot estrogen as compared to orchidectomy in the treatment of patients with prostatic carcinoma
18. The case for TNM
19. Cytological diagnosis of prostatic tumours by transrectal aspiration biopsy: A preliminary report
20. Uber Klassifikation und Grading des Prostatacarcinoms
21. Quantitative estimation of tissue prostate specific antigen, deoxyribonucleic acid ploidy and cytological grade in fine needle aspiration biopsies for prognosis of hormonally treated prostatic carcinoma
22. Tissue PSA from fine-needle biopsies of prostatic carcinoma as related to serum PSA, clinical stage, cytological grade, and DNA ploidy
23. DNA flow cytometry in carcinoma of the prostate for diagnosis, prognosis and study of tumor biology